Also found in: Acronyms, Wikipedia.



an archaeological culture of the Aeneolithic epoch and the early Bronze Age in Sind and southern Baluchistan (Pakistan). Named after findings at the site of the village of Amri (Sind).

The Amri culture was investigated by the Indian archaeologist N. Majumdar from 1934 to 1935. It is characterized by glazed painted ceramic ware with geometric ornamentation. At some sites Amri ceramics are found under a layer containing Harappa ceramics, so that the Amri culture can be regarded as pre-Harappa or early Harappa (fourth to third millennia B.C.). The Amri culture displays a similarity to the cultures of Iran and Middle Asia (Annau) and a link with the cultures of northern Baluchistan (findings at Nal).


Wheeler, M. The Indus Civilization. Cambridge, 1953.
Piggott, S. Prehistoric India to 1,000B.C. Harmondsworth, [1950].
References in periodicals archive ?
AMRI will transition activities at the Holywell site to other facilities within the AMRI network and plans to cease operations at the site by the end of 2015.
OsoBio is recognized as a premier contract manufacturer of highly complex injectable drug products and their expertise in large-scale commercial production is highly complementary to AMRI s early stage drug product manufacturing capabilities.
Our partnership with AMRI is another example of how Lilly is transforming the way it conducts R&D, enabling our scientists to discover potential new medicines in as proficient a manner as possible," said Alan Palkowitz, Ph.
With this change, AMRI has improved line-of-sight of all global operations across all of its service offerings and all of its locations.
Rajesh Shenoy, managing director, AMRI India will be relocating back to the United States to assume the position of director, project management-pharmaceutical services, continuing to report to Dr.
Henderson joined AMRI in February 2011, and is responsible for leading all of AMRI's legal, mergers and acquisitions and corporate affairs activities for the company's locations worldwide, including the United States, Europe and Asia.
Since joining AMRI in 2008, Chris has consistently demonstrated his commercial and strategic leadership abilities generating value for AMRI's customers while driving top and bottom line growth across all of AMRI's business units in Discovery, Development, API, and Drug Product.
Ladin brings more than 20 years of finance, accounting and tax management experience to AMRI.
Oso Biopharmaceutical Manufacturing was acquired by AMRI in July 2014.
Prior to AMRI, he was a director at Dishman Japan Ltd, responsible for sales and business development activities.
We remain committed to our total integrated discovery and development services platform and the capabilities for which Syracuse has become distinguished, and we will be transitioning and consolidating those activities to other sites within AMRI.